EVALUATE THE SAFETY AND INITIAL RESULTS OF APPLYING THE TECHNIQUE OF TREATING LUNG CANCER BY MICROWAVE ABLATION UNDER THE GUIDANCE OF COMPUTED TOMOGRAPHY
Từ khóa:
microwave ablation of lung tumors, lung cancerTóm tắt
A retrospective, cross-sectional study to evaluate the safety and initial results of applying the technique of treating lung cancer by microwave ablation under the guidance of computed tomography in 30 patients with non-small cells primary lung cancer, at the National Lung Hospital, from June 2018 to August 2020.
Results: The average age of patients was 61.9 ± 6.5 years; male/female ratio was 14/1; 56.7% of patients had a history of multimodality therapy. The features on computed tomography film: the average tumor size was 37.94 mm; most of the lung tumors have peripheral locations (84.0%), solid tumors (93.5%), have mediastinal lymph nodes (50.0%). The proportion of patients treated with microwave ablation under the guidance of computed tomography: 1 time (60.0%), 2 times (33.3%), and 3 times (6.7%). The average burning time for lung tumors was 13.67 ± 5.3 minutes. Damage response after performing microwave ablation under the guidance of computed tomography: 15/23 patients (65.2%) had complete tumor necrosis and 8/23 patients (34.8%) had necrosis, not a complete tumor. 36.7% of patients had complications and 36.7% of patients had unwanted reactions. The average hospital stay after performing microwave ablation under the guidance of computed tomography was 11.2 ± 4.6 days. The rate of local recurrence was 18.2%, the rate of new metastasis was 22.7%.
Tài liệu tham khảo
Ministry of Health (2018), Guidelines for the diagnosis and treatment of non-small cell lung cancer, Decision No. 4825/QD-BYT.
Nguyen Manh Quoc, Nguyen Chan Hung, Pho Duc Man, Nguyen Quoc Truc (1998), “Results of cancer registration in Ho Chi Minh City in 1997”, Oncology subsection, 3 (Ho Chi Minh City Medicine).
Bui Cong Toan (2012), "Evaluate the results of treatment of stage III non-small cell lung cancer in women with chemotherapy concurrently with 3D radiotherapy", Vietnam Medical Journal, 2, p. 49-54.
Nguyen Huy Luc, Pham Thi Kim Nhung (2016), "Clinical and subclinical characteristics in lung cancer patients at the Tuberculosis and lung disease department, 103 Military Hospital", Journal of Military Medicine and Pharmacy, number 6, p. 153-159.
Protocol to guide the assessment of microwave tissue ablation for primary and secondary lung cancer (2016), Department of Health of medical services advisory committee.
L Zhong et al (2017), “Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation”, J Thorac Dis, 9 (3), pp. 590-597.
Pusceddu et al (2019), “Usefulness of percutaneous microwave ablation for large non-small cell lung cancer: A preliminary report”, Oncol Lett, 18 (1), pp. 659-666.
H Zhao, K Steinke (2020), “Long-term outcome following microwave ablation of early-stage non-small cell lung cancer”, J Med Imaging Radiat Oncol.
X Yang et al (2018), “Microwave ablation for lung cancer patients with a single lung: Clinical evaluation of 11 cases”, Thorac Cancer, 9 (5), pp. 548-554.
A.W.P Maxwell, T.T Healey, D.E Dupuy (2017), “Microwave Ablation of Lung Tumors Near the Heart: A Retrospective review of short-term procedural safety in 10 patients”, Cardiovasc Intervent Radiol, 40 (9), pp. 1401-1407.
M Cheng, M Fay, K Steinke (2016), “Percutaneous CT-guided thermal ablation as salvage therapy for recurrent non-small cell lung cancer after external beam radiotherapy: A retrospective study”, Int J Hyperthermia, 32 (3), pp. 316-23.
F Cao et al (2019), “Safety and efficacy of thermal ablation for subpleural lung cancers”, Thorac Cancer, 10 (6), pp. 1340-1347.
B Jiang et al (2018), “Efficacy and safety of thermal ablation of lung malignancies: A Network meta-analysis”, Ann Thorac Med, 13 (4), pp. 243-250.
WHO (2018), “Global Cancer Observatory”, https://gco.iarc.fr/.
X Ye et al (2018), “Expert consensus work-shop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition)”, Journal Cancer Res Ther. 14 (4), pp. 730-744.
